Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Keras Resources restarts activities at Nayega mine

(Sharecast News) - Keras Resources announced the resumption of activities at the Nayéga manganese mine in Northern Togo on Thursday, after signing a cooperation agreement with the Republic of Togo on 17 May. The AIM-traded firm said that under the agreement, the state, through its wholly-owned investment company Société Togolaise de Manganèse (STM), was overseeing a public-private partnership award procedure to appoint a contractor to manage all activities at Nayéga.

It said the successful bidder of the ongoing tender process would be tasked with managing mining and processing operations at Nayéga, and providing a comprehensive logistics solution from the mine to the port.

The tender process was set to end on 7 June, with the requirement for the awarded contractor to be fully mobilised within six months after that.

Keras said the state had already started mobilisation efforts at Nayéga to ensure infrastructure readiness, including water pipelines and access roads, for the prompt re-establishment of operations.

The timing of the tender process aligned favourably with recent market trends in the manganese industry, the board said, as it had experienced a rebound from a prolonged period of low prices.

Given Nayéga's operational readiness, it was potentially poised to swiftly capitalise on the market upswing.

Keras previously disclosed advisory and brokerage agreements with the Togo, entailing a 1.5% advisory fee on gross revenue generated from the Nayéga mine for three years, and a 6.0% brokerage fee on gross revenue for the provision of brokerage services, applicable to the lesser of 3.5 years or 900,000 tonnes of beneficiated manganese ore produced and sold from Nayéga.

"The mobilisation of key staff at Nayéga and the issue of a request for tender for the management of the Nayéga operation is a significant step forward in the development of this asset which the company fully supports and is very much in line with the 2023 cooperation agreement we have with STM and sets a clear picture of how the asset will now be developed to benefit all stakeholders including Keras," said chief executive officer Graham Stacey.

"We look forward to working closely with the management team of STM.

"The progress at Nayéga is very positive for Keras from an additional cashflow perspective and will underpin what has been a hugely productive 6 months at the company's flagship operation in Utah, where its subsidiary Falcon Isle Resources, now operating from its 100% owned facility in Delta, is finalising the construction of a fully integrated granulator plant to produce Phosul granules under the joint venture with partners, Phosul."

Stacey said the Phosul production line would augment the already-installed processing infrastructure producing sized dry rock phosphate products from the high-grade Diamond Creek phosphate mine.

"I look forward to updating shareholders on a continuous basis as we move forward on these two fronts."

At 1137 BST, shares in Keras Resources weer up 4% at 2.08p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Pressures are building for Imperial Brands, says Jefferies
(Sharecast News) - Jefferies has lifted its target price for Imperial Brands following a strong set of first-half results from the cigarette, tobacco and vape group last week, but has maintained a 'hold' rating, saying that pressures are building for the company.
ShoreCap says NatWest entering fair value territory, downgrades
(Sharecast News) - Shore Capital downgraded NatWest on Monday to 'hold' from 'buy' as it said the shares were "entering fair value territory".
PureTech Health launches $100m tender offer
(Sharecast News) - Clinical-stage biotherapeutics company PureTech Health launched a proposed $100m tender offer on Monday, aiming to repurchase shares at a fixed price of 250p each, or £25.00 per American depositary share (ADS).
Helical sells 50pc stake in City redevelopment
(Sharecast News) - Helical announced on Monday that it has sold a 50% stake in the redevelopment of 100 New Bridge Street, London EC4, to a vehicle led by Orion Capital Managers, for £55m on a preferred equity basis.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.